<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology, clinical presentation, and diagnostic evaluation of parapneumonic effusion and empyema in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology, clinical presentation, and diagnostic evaluation of parapneumonic effusion and empyema in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology, clinical presentation, and diagnostic evaluation of parapneumonic effusion and empyema in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charlie Strange, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">V Courtney Broaddus, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Julio A Ramirez, MD, FACP</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheila Bond, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 25, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>A parapneumonic effusion is a pleural effusion that forms in the pleural space adjacent to a pneumonia. When microorganisms infect the pleural space, a complicated parapneumonic effusion or empyema may result. An empyema can also develop in the absence of an adjacent pneumonia.</p><p>The epidemiology, microbiology, clinical presentation, and diagnostic evaluation of parapneumonic effusions and empyema are reviewed here. The management of parapneumonic effusions and empyema in adults and children is discussed separately. (See  <a class="medical medical_review" href="/d/html/119384.html" rel="external">"Management and prognosis of parapneumonic pleural effusion and empyema in adults"</a> and  <a class="medical medical_review" href="/d/html/6344.html" rel="external">"Epidemiology, clinical presentation, and evaluation of parapneumonic effusion and empyema in children"</a> and  <a class="medical medical_review" href="/d/html/6345.html" rel="external">"Management and prognosis of parapneumonic effusion and empyema in children"</a>.)</p><p class="headingAnchor" id="H1551030233"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>A parapneumonic effusion refers to the accumulation of fluid in the pleural space in the setting of an adjacent pneumonia  (<a class="graphic graphic_table graphicRef121161" href="/d/graphic/121161.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>An uncomplicated or simple parapneumonic effusion refers to a free-flowing effusion that is sterile.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A complicated parapneumonic effusion refers to an effusion that has been infected with bacteria or other microorganisms (eg, positive Gram stain or biochemical evidence of marked inflammation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An empyema refers to a collection of pus within the pleural space, which can develop when pyogenic bacteria, fungi, parasites, or mycobacteria invade the pleural space, either from an adjacent pneumonia or from direct inoculation (eg, from penetrating trauma) or other source. Empyema that develops from an adjacent pneumonia is a subclass of a complicated parapneumonic effusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A complex effusion refers to an effusion with internal loculations.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A uniloculated effusion is one that is without internal septae (free-flowing or fixed).</p><p></p><p class="headingAnchor" id="H1584807034"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H3580923223"><span class="h2">Incidence</span><span class="headingEndMark"> — </span>Parapneumonic effusions and empyema are relatively common complications of pneumonia. Since the advent of antibiotics, their overall incidence has declined dramatically to approximately two to three percent of all pneumonias [<a href="#rid1">1</a>]. However, epidemiologic studies suggest that rates are again slowly rising [<a href="#rid2">2-5</a>]. As examples, one study of 4424 patients with empyema reported an increase in the incidence by 2.8 percent per year between the years of 1987 and 2004 [<a href="#rid6">6</a>]. Similarly, another study of over 11,000 patients admitted to hospital with empyema found a 2.2-fold rise in the incidence of pleural infection between 1995 and 2003 in patients &lt;19 years and a 1.2-fold rise in patients &gt;19 years of age [<a href="#rid2">2</a>]. Continued increases have been noted from 2008 to 2018 in the United Kingdom, particularly in those aged &gt;60 years, with a seasonal variability associated with influenza infections [<a href="#rid7">7</a>].</p><p>Rates are highest in hospitalized patients with one report suggesting that 20 to 40 percent of patients hospitalized with pneumonia have a parapneumonic effusion and 5 to 10 percent of those progress to empyema (ie, about 32,000 patients per year) [<a href="#rid3">3</a>].</p><p>Differences in reporting rates between studies may reflect differences in how studies define parapneumonic effusion; studies evaluating the incidence of computed tomography (CT)-defined fluid in pneumonia report higher rates than those that are defined by fluid chemistry and culture.</p><p>Empyema may be more common in men than women, although the reasons for this are unknown [<a href="#rid8">8-10</a>].</p><p class="headingAnchor" id="H2815284246"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Other than risk factors for the development of pneumonia, commonly cited risk factors for the development of a parapneumonic effusion include aspiration, poor dental hygiene, malnutrition, and alcohol or intravenous drug abuse [<a href="#rid11">11-15</a>]. Others include immunosuppression, age (&lt;18 years, &gt;65 years), partially treated pneumonia, influenza [<a href="#rid7">7</a>], and gastroesophageal reflux. (See  <a class="medical medical_review" href="/d/html/117561.html" rel="external">"Overview of community-acquired pneumonia in adults", section on 'Risk factors'</a>.)</p><p>Prior use of inhaled glucocorticoids for chronic obstructive pulmonary disease (COPD) or asthma has been associated with reduced incidence of parapneumonic effusions [<a href="#rid16">16</a>], a surprising outcome given the increased incidence of community acquired pneumonia (CAP) in these patients. The reason for this inverse association is unknown but may be due to an altered inflammatory response from inhaled glucocorticoids or due to a lower threshold to seek medical attention in patients with asthma or COPD.</p><p>The presence of preexisting pleural fluid (eg, secondary to heart failure, liver disease) also favors growth of microorganism in the pleural space and is likely a contributing factor in the risk for developing pleural space infections.</p><p class="headingAnchor" id="H865485348"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Most parapneumonic effusions and empyemas are due to underlying pneumonia, and are believed to develop in three stages  (<a class="graphic graphic_figure graphicRef121168" href="/d/graphic/121168.html" rel="external">figure 1</a>). Patients can present at any stage of development  (<a class="graphic graphic_table graphicRef121162" href="/d/graphic/121162.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H3657398744"><span class="h2">Stage 1 (simple or uncomplicated parapneumonic effusion)</span><span class="headingEndMark"> — </span>Stage 1 is an early stage of development when interstitial fluid increases during pneumonia and moves across the adjacent visceral pleural membrane. In this stage, fluid is free-flowing and has exudative characteristics with a protein content greater than 0.5 of the serum value and/or a lactate dehydrogenase (LDH) level more than 0.6 than in the serum (but usually &lt;1000 international units [IU]/L). The white cell count is variable but typically has neutrophilic predominance. Fluid will have a normal pH and glucose level and no evidence to support infection with microorganisms. (See <a class="local">'Thoracentesis and pleural fluid analysis'</a> below.)</p><p class="headingAnchor" id="H1024290626"><span class="h2">Stage 2 (complicated parapneumonic effusion and empyema)</span><span class="headingEndMark"> — </span>Stage 2 is a fibrinopurulent stage, whereby bacterial invasion across the damaged pleural mesothelium stimulates an inflammatory response resulting in fibrin deposition and loculations within the pleural space. Characteristic findings include an exudative effusion with a high white cell count, pH &lt;7.20, glucose &lt;2.2 mmol/L (&lt;40 mg/dL) and LDH &gt;1000 IU/L. Without pus, this is termed a complicated parapneumonic effusion, but if frank pus is found, then this is called an empyema. Notably, it is possible that fluid characteristics may vary among pockets of fluid/loculations. (See <a class="local">'Thoracentesis and pleural fluid analysis'</a> below.)</p><p>Empyema can also present independently of pneumonia, when bacteria or other pathogens directly inoculate or invade the pleural space  (<a class="graphic graphic_figure graphicRef121168" href="/d/graphic/121168.html" rel="external">figure 1</a>). In these cases, empyema can be due to esophageal rupture, blunt or penetrating chest trauma, hematogenous spread, mediastinitis with pleural extension, bronchogenic carcinoma that has breached the pleura allowing bacterial translocation, infected congenital cysts of the airway or esophagus, or extension from sources outside the thorax (eg, liver abscess or cervical or thoracic spine infections). Postsurgical etiologies (eg, bronchopleural fistula from lobectomy) can also be independent of pneumonia.</p><p class="headingAnchor" id="H2913035813"><span class="h2">Stage 3 (chronic organization)</span><span class="headingEndMark"> — </span>In stage 3, the pleural fluid begins to organize [<a href="#rid17">17</a>]. In the later stages, a fibrinous pleural covering ("fibrous peel") develops and may encase the lung, hindering full re-expansion (trapped lung), impairing lung function, and creating the potential for additional infection. In many cases, pleural fluid has been organized and cannot be withdrawn for analysis. This thickened pleura usually resolves over three to six months but in some cases forms a true scar. (See  <a class="medical medical_review" href="/d/html/6697.html" rel="external">"Diagnosis and management of pleural causes of nonexpandable lung"</a>.)</p><p class="headingAnchor" id="H2419436438"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>Pyogenic bacteria such as <em>Streptococcus pneumoniae</em>, oral streptococci and anaerobes, and <em>Staphylococcus aureus</em> are the most common causes of parapneumonic effusions and parapneumonic empyema  (<a class="graphic graphic_table graphicRef121163" href="/d/graphic/121163.html" rel="external">table 3</a>) [<a href="#rid15">15,18</a>]. Parapneumonic pleural space infections that result from community acquired pneumonia (CAP) tend to be caused by the pyogenic bacteria that cause CAP (eg, <em>S. pneumoniae</em>, <em>S. aureus</em>). Parapneumonic pleural space infections that result from aspiration tend to be polymicrobial and caused by oral streptococci and anaerobes. However, the spectrum of potential pathogens is wide and varies based on the route of acquisition (eg, parapneumonic versus nonparapneumonic), site of acquisition (eg, community or hospital-acquired) and geography  (<a class="graphic graphic_figure graphicRef121168" href="/d/graphic/121168.html" rel="external">figure 1</a>) [<a href="#rid15">15,18,19</a>].</p><p>For nonparapneumonic complicated pleural effusions and empyema, the list of causative organisms is more extensive and varies considerably with the source  (<a class="graphic graphic_figure graphicRef138637" href="/d/graphic/138637.html" rel="external">figure 2</a>). For example, empyema that results from diaphragmatic translocation from an intraabdominal infection is likely caused by gastrointestinal flora. Thus, the infection source, local epidemiology, and patient-specific risk factors are important when evaluating a patient with nonparapneumonic empyema.</p><p>It is prudent that the clinician be aware of their local microbiology and antibiotic resistance patterns and be cognizant of the likelihood of infections that are polymicrobial (eg, coexisting anaerobes).</p><p class="headingAnchor" id="H2906709105"><span class="h2">Bacteria</span><span class="headingEndMark"> — </span><em>S. pneumoniae</em> (pneumococcus) is the most common bacterial cause of CAP, and among the most common causes of community-acquired parapneumonic effusions and empyema. The reported prevalence varies among studies, ranging from approximately 10 to 20 percent of culture-positive cases [<a href="#rid15">15,20-22</a>]. (See  <a class="medical medical_review" href="/d/html/7013.html" rel="external">"Pneumococcal pneumonia in patients requiring hospitalization", section on 'Pleural effusion and empyema'</a>.)</p><p>Microaerophilic streptococci (eg, <em>S. anginosus, S. intermedius, S. constellatus) </em>and anaerobes, which colonize the oropharynx, are leading causes of empyema, and presumably reach the pleural space by spread from aspiration pneumonia [<a href="#rid4">4,15,21,23</a>]. Empyema related to aspiration is often polymicrobial. Among anaerobes the most frequently isolated organisms include <em>Fusobacterium </em>species (eg, <em>F. nucleatum</em>), <em>Prevotella</em> species, <em>Peptostreptococcus</em> species, and <em>Bacteroides</em> species (eg, <em>B. melaninogenicus</em>; <em>B. fragilis</em>) [<a href="#rid9">9,11,24-26</a>]. Anaerobic bacteria have been cultured in 36 to 76 percent of human empyemas [<a href="#rid24">24,27</a>]. (See  <a class="medical medical_review" href="/d/html/7024.html" rel="external">"Aspiration pneumonia in adults", section on 'Microbiology'</a> and  <a class="medical medical_review" href="/d/html/5520.html" rel="external">"Anaerobic bacterial infections"</a> and  <a class="medical medical_review" href="/d/html/5520.html" rel="external">"Anaerobic bacterial infections", section on 'Pleuropulmonary infections'</a>.)</p><p><em>Staphylococcus aureus</em> accounts for approximately 10 to 15 percent of parapneumonic effusions and empyema overall [<a href="#rid15">15,18,21</a>]. The prevalence of <em>S. aureus</em> is highest among hospital-acquired empyemas (accounting for approximately one-third of cases), but <em>S. aureus</em> empyema can also occur secondary to CAP. Gram-negative rods, including <em>Escherichia coli</em>, other Enterobacteriaceae, <em>Pseudomonas aeruginosa,</em> and <em>Klebsiella</em> species, collectively account for approximately 8 to 10 percent of cases [<a href="#rid15">15,21</a>].</p><p>Atypical bacteria, such as <em>Legionella,</em> <em>Mycoplasma,</em> and <em>Chlamydia</em> species, are rare but reported causes of parapneumonic effusions and empyema. (See  <a class="medical medical_review" href="/d/html/7035.html" rel="external">"Clinical manifestations and diagnosis of <i>Legionella </i>infection"</a> and  <a class="medical medical_review" href="/d/html/6989.html" rel="external">"<i>Mycoplasma pneumoniae</i> infection in adults"</a> and  <a class="medical medical_review" href="/d/html/6989.html" rel="external">"<i>Mycoplasma pneumoniae</i> infection in adults", section on 'Pneumonia'</a>.)</p><p>The relative prevalence of pathogens also varies with geography. As an example, <em>Burkholderia pseudomallei</em> is endemic in Southeast Asia, South Asia, and northern Australia. In areas of high prevalence, such as Thailand, <em>B. pseudomallei</em> is a common cause of pneumonia, and has been reported to cause up to 20 percent of pleural infections [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/3146.html" rel="external">"Melioidosis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p>Selected patients may also have increased risk of specific organisms. Patients with diabetes mellitus are at increased risk of empyema secondary to <em>Klebsiella pneumoniae</em> [<a href="#rid29">29</a>]. In patients with influenza, the major causes of bacterial superinfection and empyema have been <em>Staphylococcus aureus</em>, <em>Streptococcus pneumoniae,</em> and <em>Streptococcus pyogenes</em> [<a href="#rid30">30</a>]. Anaerobic empyema with aspiration pneumonia often is seen in the aspiration-prone patient who presents relatively late in the infection with pneumonitis involving the superior segment of a lower lobe or posterior segment or an upper lobe.</p><p class="headingAnchor" id="H1163430664"><span class="h2">Mycobacteria</span><span class="headingEndMark"> — </span>Mycobacterial effusion and empyema are considerably less frequent than bacterial empyema, and usually result from reactivation of latent tuberculosis (TB) in the subjacent lung or pleural space. Tuberculous empyema should be considered in patients who live in an endemic area and/or who have risk factors for TB. [<a href="#rid31">31</a>]. Tuberculous empyema, in which the TB organism can be found by stain or by culture in the pleural effusion, should be differentiated from tuberculous pleurisy in which a lymphocytic effusion occurs from the immunologic response to tuberculous proteins and the TB organisms are few and only reliably found in the pleural tissue. Further details regarding the manifestations of tuberculous empyema are discussed separately. (See  <a class="medical medical_review" href="/d/html/8012.html" rel="external">"Tuberculous pleural effusion"</a>.)</p><p>Less commonly, atypical mycobacteria are also associated with parapneumonic effusion and empyema, (eg, <em>Mycobacterium abscessus, Mycobacterium avium, Mycobacterium kansasii</em>) [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/5342.html" rel="external">"Overview of nontuberculous mycobacterial infections"</a>.)</p><p class="headingAnchor" id="H275919204"><span class="h2">Other pathogens</span><span class="headingEndMark"> — </span>Fungal pleural infection is rare (&lt;1 percent of cases) with <em>Candida </em>species being responsible for the majority of cases [<a href="#rid33">33</a>]. Candida pneumonia and empyema typically occur in the setting of disseminated infections in highly immunocompromised patients or, in the case of empyema, as a complication of thoracic surgery [<a href="#rid33">33</a>]. Aspiration of <em>Candida</em> from the oropharynx is unlikely to cause either pneumonia or empyema. (See  <a class="medical medical_review" href="/d/html/2436.html" rel="external">"Candida infections of the abdomen and thorax"</a>.)</p><p>Less commonly reported fungal pleural infections are caused by cryptococcus and <em>Aspergillus</em> species, both of which most often occur in immunocompromised hosts [<a href="#rid33">33,34</a>].</p><p>Parasites are rare causes of pleural infections, but <em>Entamoeba histolytica</em>, <em>Echinococcus granulosus</em> and <em>Paragonimus westermani </em>can cause pleural effusions [<a href="#rid35">35,36</a>].</p><p>Viruses do not typically cause empyema. For example, no influenza viruses were detectable by polymerase chain reaction in any pleural fluid samples in a prospective study evaluating pleural space infections following influenza [<a href="#rid7">7</a>]. However, secondary bacterial infections can complicate viral pneumonias. As an example, in patients with influenza, the major causes of bacterial superinfection and empyema have been <em>Staphylococcus aureus</em>, <em>Streptococcus pneumoniae,</em> and <em>Streptococcus pyogenes</em> [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>The clinical findings of a parapneumonic effusion and empyema are nonspecific and, with the exception of decreased fremitus, overlap with those of pneumonia. Among those with pneumonia, risk factors for empyema (eg, aspiration), and persistent or new fever, and/or lack of clinical response despite appropriate antibiotics should heighten the suspicion for the development of a parapneumonic effusion or an empyema.</p><p class="headingAnchor" id="H723875803"><span class="h2">History and examination</span><span class="headingEndMark"> — </span>Common clinical features on history include cough, fever, pleuritic chest pain, dyspnea, and sputum production. Compared with those with pneumonia alone or pneumonia with simple parapneumonic effusion, patients with empyema may report a longer course with several days of fever and malaise, with one trial reporting duration of symptoms as long as two weeks [<a href="#rid8">8</a>]. Presentation may also be more insidious and delayed in patients with anaerobic infections (eg, those with aspiration, poor dental hygiene) with some patients presenting with loss of appetite and weight loss over weeks to months [<a href="#rid11">11-13</a>].</p><p>Physical examination may identify the presence of pleural fluid with dullness on percussion, decreased breath sounds, and decreased fremitus. Occasionally, egophony (e-to-a sound) is present at the upper edge of the effusion. Although decreased vocal fremitus classically differentiates a pleural effusion from lung consolidation (associated with increased vocal fremitus), these findings are often absent and therefore, not useful. Thus, radiographic imaging is crucial to the complete evaluation. (See <a class="local">'Diagnostic imaging'</a> below.)</p><p class="headingAnchor" id="H3255532247"><span class="h2">Laboratory findings</span><span class="headingEndMark"> — </span>There are no specific laboratory blood tests that are diagnostic of a parapneumonic effusion. Laboratory findings usually reflect that of infection such as leukocytosis, left shift, elevated C-reactive protein. In some cases, bacteremia can co-occur and the infecting organism can be identified from blood cultures (up to 12 percent of cases) [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/d/html/7032.html" rel="external">"Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H1899400029"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>Our approach is generally similar to that outlined by the American Association for Thoracic Surgery (AATS), the European Association for Cardio-Thoracic Surgery (EACTS), the American College of Chest Physician (ACCP), the British Thoracic Society (BTS) pleural disease guideline development group, and the European Respiratory Society/European Society of Thoracic Surgeons group  (<a class="graphic graphic_algorithm graphicRef122289" href="/d/graphic/122289.html" rel="external">algorithm 1</a>) [<a href="#rid37">37-41</a>].</p><p class="headingAnchor" id="H1637142100"><span class="h2">Diagnostic imaging</span><span class="headingEndMark"> — </span>Chest radiography, ultrasonography, and CT all play a key role in the evaluation and management of parapneumonic effusions and empyema [<a href="#rid42">42</a>]. In all patients with pneumonia in whom recent imaging has not been obtained, the chest radiograph should be the initial imaging modality obtained for evidence of pleural fluid. Once a pleural effusion is detected on chest radiography, ultrasonography is typically performed at the bedside to evaluate the nature of the effusion and feasibility of sampling or drainage. CT is generally performed when complications (eg, loculations) are suspected, complex interventions are planned, and/or more detail of the underlying anatomy is expected to help with management.</p><p>All three imaging modalities have their advantages and disadvantages and have been inadequately compared. However, one retrospective analysis of 66 patients suggested that ultrasonography was more sensitive than chest radiography (69 versus 61 percent) but less sensitive than CT (69 versus 76 percent) for the diagnosis of a complicated parapneumonic effusion [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/6688.html" rel="external">"Imaging of pleural effusions in adults"</a>.)</p><p>Magnetic resonance imaging (MRI) and positron emission tomographic scanning are not useful, although MRI may be valuable when chest wall or spinal involvement is suspected [<a href="#rid44">44</a>]. Their role in evaluating effusions due to malignancy is discussed separately. (See  <a class="medical medical_review" href="/d/html/4399.html" rel="external">"Imaging of pleural plaques, thickening, and tumors"</a> and  <a class="medical medical_review" href="/d/html/4632.html" rel="external">"Overview of the initial evaluation, diagnosis, and staging of patients with suspected lung cancer", section on 'Clinical-directed imaging'</a>.)</p><p>Rarely, additional imaging may be required for those with empyema not associated with pneumonia, including contrast imaging for the esophagus when a ruptured esophagus is suspected, or CT of the abdomen when empyema due to an intraabdominal process (eg, liver abscess) is suspected  (<a class="graphic graphic_figure graphicRef138637" href="/d/graphic/138637.html" rel="external">figure 2</a>).</p><p class="headingAnchor" id="H4128184019"><span class="h3">Chest radiography</span><span class="headingEndMark"> — </span>Most parapneumonic effusions or empyemas are initially suspected during the routine evaluation of patients with suspected or known pneumonia.</p><p>Free-flowing pleural effusions accumulate in the most dependent part of the thoracic cavity [<a href="#rid45">45</a>]. In an upright patient, some free-flowing effusions are subtle lying in a subpulmonic location (&lt;75 mL). Other pleural effusions can be appreciated on lateral chest radiography as blunting of the posterior costophrenic angle (&gt;75 mL) or on anteroposterior chest radiography as blunting of the lateral costophrenic angle (&gt;175 mL), while large effusions may obscure the diaphragm (&gt;500 mL) and demonstrate a meniscus sign. Occasionally, the entire hemithorax may be occupied by an effusion with associated underlying lung collapse.</p><p>However, chest radiography has limitations. The meniscus sign and dependent layering of fluid is often absent in complex/loculated parapneumonic effusions where the radiograph may show a lenticular pleural-based opacity  (<a class="graphic graphic_diagnosticimage graphicRef73968" href="/d/graphic/73968.html" rel="external">image 1</a>). In addition, large effusions may hide underlying pneumonia and large consolidations may hide small effusions; in both situations the threshold to obtain an ultrasound and/or chest CT should be low. Demonstrating such limitations, in a study of 61 patients with chest CT-proven parapneumonic effusions, anteroposterior and lateral chest radiography missed approximately 10 percent of pleural effusions, in most cases due to the coexistence of lower lobe consolidation [<a href="#rid46">46</a>]. Additional details regarding radiographic characteristics of pleural effusions are discussed separately. (See  <a class="medical medical_review" href="/d/html/6688.html" rel="external">"Imaging of pleural effusions in adults", section on 'Conventional radiography'</a>.)</p><p>In the past, lateral decubitus radiographs were often performed to determine the extent to which an effusion is freely flowing within the pleural space and evaluate the safety of thoracentesis. As the availability of ultrasonography and CT advances, this test is rarely performed. (See <a class="local">'Thoracentesis and pleural fluid analysis'</a> below.)</p><p class="headingAnchor" id="H79490216"><span class="h3">Ultrasonography</span><span class="headingEndMark"> — </span>Free-flowing or loculated pleural effusions as well as underlying consolidation or solid masses can be appreciated on chest ultrasonography. Ultrasonography is now typically performed at the bedside for most pleural effusions to evaluate the size and characteristics of the effusions. Although ultrasonography is best utilized for selecting and guiding needle or catheter placement for thoracentesis, it also provides important prognostic and therapeutic information [<a href="#rid47">47</a>]. Data that support the use of pleural ultrasonography are discussed separately. (See  <a class="medical medical_review" href="/d/html/14888.html" rel="external">"Bedside pleural ultrasonography: Equipment, technique, and the identification of pleural effusion and pneumothorax", section on 'Identification of pleural effusion using ultrasonography'</a> and  <a class="medical medical_review" href="/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis"</a>.)</p><p class="headingAnchor" id="H1549719689"><span class="h3">Chest computed tomography</span><span class="headingEndMark"> — </span>Chest CT (typically with intravenous contrast to help identify the pleural membranes) is the most sensitive method for detecting small amounts of pleural fluid (&gt;2 mL). CT can also easily appreciate loculations  (<a class="graphic graphic_diagnosticimage graphicRef80445" href="/d/graphic/80445.html" rel="external">image 2</a>) and underlying airway, pleural, and parenchymal abnormalities (eg, pneumonia, abscess, fistulae, diaphragmatic defects, esophageal rupture, or masses that suggest underlying cancer) as well as chest tube positioning [<a href="#rid48">48-50</a>].</p><p>During the fibrinopurulent and organizing stages of complicated parapneumonic effusions and empyema (see <a class="local">'Pathogenesis'</a> above), radiographic contrast enhancement of the pleural surfaces assists in delineating pleural fluid loculations and in characterizing empyema. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Loculations, often lenticular in shape, may be appreciated by tapered borders and obtuse angles between the fluid and the chest wall with an absence of the meniscus sign.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Parietal pleural thickening is seen in 86 percent and pleural enhancement in 96 percent of patients with empyema [<a href="#rid49">49</a>]. Thickening of the visceral and parietal pleura is suggestive of empyema when associated with significant (usually &gt;30 mm) separation of the pleural surfaces (split pleura sign), which can be appreciated in up to 68 percent of patients [<a href="#rid49">49,51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural infection is also associated with increased attenuation of extracostal fat [<a href="#rid49">49</a>].</p><p></p><p>Air within the pleural fluid (eg, pockets or bubbles of air, gas-liquid level) may suggest associated pneumothorax, bronchopleural fistula, air introduced during thoracentesis, a nonexpandable lung after pleural drainage or rarely gas-producing anaerobic organisms.</p><p>Older empyemas that have spontaneously organized and remained undetected over years may exhibit minor or major calcification (eg, tuberculous empyema).</p><p>Distinguishing pleural fluid from pleural masses and distinguishing empyema from a lung abscess are discussed below. (See <a class="local">'Differential diagnosis'</a> below.)</p><p class="headingAnchor" id="H8"><span class="h2">Thoracentesis and pleural fluid analysis</span><span class="headingEndMark"> — </span>Most cases of suspected parapneumonic effusion or empyema should at minimum be sampled unless the effusion is too small or sampling is deemed unsafe [<a href="#rid52">52</a>]. Results guide further management of the effusion. Diagnostic thoracentesis is typically performed under ultrasound guidance. In some cases, therapeutic thoracentesis is simultaneously performed when symptomatic relief is needed or when drainage is indicated (eg, frank pus is observed). Indications and contraindications and technique for thoracentesis are discussed separately. (See  <a class="medical medical_review" href="/d/html/6686.html" rel="external">"Ultrasound-guided thoracentesis"</a> and  <a class="medical medical_review" href="/d/html/14888.html" rel="external">"Bedside pleural ultrasonography: Equipment, technique, and the identification of pleural effusion and pneumothorax"</a>.)</p><p>In the past, it was considered safe to sample pleural fluid when a free-flowing effusion was demonstrated on chest radiography with at least 1 cm depth to the chest wall on a lateral decubitus film [<a href="#rid53">53</a>]. However, most pleural effusions are now sampled under ultrasound guidance; since there is no definition of what is considered a "safe" amount for sampling by ultrasonography, much of this decision is at the discretion of the ultrasonographer, although most experts would consider a pleural space of &gt;1 cm (between parietal and visceral pleural) safe. Occasionally, CT guidance may be needed for sampling fluid, particularly fluid that is located in small loculated pockets within the pleural space; in such cases, the largest and most accessible loculation is generally chosen. A pleural fluid thickness cutoff of 2 to 2.5 cm has been suggested to guide thoracentesis by chest CT, because smaller effusions on CT are likely to resolve with antibiotics alone [<a href="#rid54">54,55</a>].</p><p>Fluid obtained by thoracentesis should be sent for the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cell count with differential and chemistries</strong> – A total protein, lactate dehydrogenase (LDH), and glucose should be obtained together with serum values for protein and LDH. A neutrophil predominance is more common in patients with bacterial pneumonia while a lymphocyte predominance may indicate tuberculous or fungal etiologies. Distinguishing exudates from transudates is discussed separately. (See  <a class="medical medical_review" href="/d/html/6698.html" rel="external">"Pleural fluid analysis in adults with a pleural effusion", section on 'Routine pleural fluid biomarkers'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiologic analysis</strong> – Microbiologic analysis of the pleural fluid with appropriate stains and cultures (eg, aerobic, anaerobic, mycobacterial, fungal) is critical. Although sampling should ideally occur before the administration of antibiotics, thoracentesis should not delay prompt antimicrobial therapy. Samples should be drawn directly from the pleural space because cultures from previously placed catheters or tubing can be colonized or contaminated with bacteria or fungi [<a href="#rid56">56</a>].</p><p></p><p class="bulletIndent1">Pleural fluid should be inoculated directly into blood culture bottles (aerobic and anaerobic) in addition to the usual sterile containers used for standard Gram stain and culture, in order to maximize diagnostic yield [<a href="#rid57">57,58</a>]. In a series of 53 patients with suspected pleural infection and culture data from both standard and blood culture bottles obtained at the same time, the number of patients with identifiable pathogens increased by 21 percent (95% CI 8.9 to 20.8 percent) [<a href="#rid55">55</a>]. A sterile container without culture media is acceptable if only a small amount of fluid is available.</p><p></p><p class="bulletIndent1">A putrid odor of fluid is considered diagnostic of anaerobic infection; the Gram stain will also help identify anaerobes because of the unique morphology of some anaerobic Gram-negative rods. (See  <a class="medical medical_review" href="/d/html/5520.html" rel="external">"Anaerobic bacterial infections"</a> and  <a class="medical medical_review" href="/d/html/5520.html" rel="external">"Anaerobic bacterial infections", section on 'Pleuropulmonary infections'</a>.)</p><p></p><p class="bulletIndent1">Blood and pleural culture results yield a diagnosis in approximately 60 percent of cases [<a href="#rid21">21</a>]. There are several reasons why bacteria may not be identified in culture for the remaining 40 percent:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anaerobic organisms may be difficult to culture</p><p class="bulletIndent2"><span class="glyph">•</span>Anaerobic cultures are not specifically requested</p><p class="bulletIndent2"><span class="glyph">•</span>Sampling is often performed after a patient has received antibiotics</p><p class="bulletIndent2"><span class="glyph">•</span>Sterile inflammatory fluid may be aspirated adjacent to an infected loculus of infection</p><p class="bulletIndent2"><span class="glyph">•</span>Current culture methods are insufficiently sensitive</p><p class="bulletIndent2"><span class="glyph">•</span>Bacteria may be located in the pleural membranes rather than in the fluid [<a href="#rid59">59</a>]</p><p></p><p class="bulletIndent1">Some centers have begun routine molecular analysis of parapneumonic effusions to detect <em>S. pneumoniae </em>infection by rapid antigen detection assays or broad-range <em>16S</em> ribosomal DNA polymerase chain reaction. These centers report a much higher detection rate for S. pneumoniae than historical case series [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent1">Special stains and cultures should be requested when unusual organisms or organisms that require special culture conditions are suspected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>pH</strong> – The pH should be drawn directly into an arterial blood gas syringe and determined with a blood gas analyzer within one hour of sampling. Residual <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> and heparin falsely decrease the pH and air in the syringe falsely increases the pH; therefore, the same needle that is used to anesthetize the pleural space should not collect the pH sample. It is not necessary to run the sample through an analyzer if frank pus is collected since that feature is diagnostic of an empyema. (See  <a class="medical medical_review" href="/d/html/6698.html" rel="external">"Pleural fluid analysis in adults with a pleural effusion"</a>.)</p><p></p><p class="bulletIndent1">The pH is the most useful test when determining the therapeutic course, the details of which are discussed separately. (See <a class="local">'Complicated parapneumonic effusion and empyema'</a> below and  <a class="medical medical_review" href="/d/html/119384.html" rel="external">"Management and prognosis of parapneumonic pleural effusion and empyema in adults"</a>.)</p><p></p><p class="bulletIndent1">The differential diagnosis of pleural fluid acidosis, a feature typically associated with a complicated parapneumonic effusion or empyema is discussed below. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cytology</strong> – Cytologic examination for appropriate stains (eg, mycobacteria, actinomyces, nocardia) can be sent when organisms requiring special stains are needed. In addition, malignancy can cause pleural fluid acidosis; thus, sending fluid for cytology for malignant cells is prudent.</p><p></p><p>Some studies have demonstrated that pleural fluid analysis may substantially differ from one locule to another, limiting the value of pleural fluid analysis in this instance [<a href="#rid61">61</a>]. Thus, in cases where the results are inconsistent with clinical findings, repeat sampling should be considered.</p><p>Novel biomarkers of infection (eg, C-reactive protein, procalcitonin, STREM-1) in pleural fluid have been evaluated for possible utility in distinguishing empyemas from uncomplicated pleural effusions, but were found to be no more useful than the more traditional pleural chemistries [<a href="#rid62">62-66</a>]. Another retrospective study showed that higher levels of pleural vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) were associated with complicated parapneumonic effusions [<a href="#rid65">65</a>]. Further prospective studies of serum or pleural biomarkers that define a population requiring pleural fluid drainage are needed.</p><p class="headingAnchor" id="H2762947510"><span class="h2">Other tests</span><span class="headingEndMark"> — </span>Although blood cultures are frequently negative in patients with parapneumonic effusion and empyema, they should be obtained. Growth from cultures can help make the microbiologic diagnosis as well as identify concurrent bacteremia. The need for additional microbiologic testing should be determined on a case-by-case basis (eg, sputum cultures, urine <em>S. pneumoniae </em>antigen testing, interferon-gamma release assays for tuberculosis, galactomannan, cryptococcal antigen).</p><p>Procalcitonin's usefulness for distinguishing bacterial from nonbacterial parapneumonic effusions is not well studied but is not likely to be high. In one study, serum procalcitonin levels &gt;0.18 ng/mL were associated with a sensitivity of 83 percent and specificity of 81 percent for the pleural effusion having a bacterial infectious etiology [<a href="#rid64">64</a>]. However, this marker rises in the setting of invasive and systemic infections; thus the sensitivity for determining whether bacteria are present in a contained space infection is questionable. Neither high nor low procalcitonin levels are likely to change the need for drainage. (See  <a class="medical medical_review" href="/d/html/114753.html" rel="external">"Procalcitonin use in lower respiratory tract infections", section on 'Procalcitonin biology'</a>.)</p><p class="headingAnchor" id="H1815062924"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Several conditions need to be entertained when evaluating a suspected parapneumonic effusion or empyema.</p><p class="bulletIndent1"><span class="glyph">●</span>Pleural fluid exudates – The differential diagnosis of an exudative pleural effusion is listed in the table  (<a class="graphic graphic_table graphicRef54055" href="/d/graphic/54055.html" rel="external">table 4</a>). Further studies may be needed on pleural fluid or pleural biopsy may be required to distinguish these from one another, the details of which are discussed separately. (See  <a class="medical medical_review" href="/d/html/6698.html" rel="external">"Pleural fluid analysis in adults with a pleural effusion"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural fluid acidosis – Pleural fluid acidosis and/or low glucose, although highly suspicious for a complicated parapneumonic pleural effusion or empyema, can be associated with other diseases including malignancy, tuberculosis, rheumatoid pleuritis, lupus pleuritis, and urinothorax [<a href="#rid67">67</a>]. It may also be seen in patients who have a central venous catheter that is misplaced in the pleural space and is infusing isotonic fluid such as <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>. These conditions can be excluded when clinically indicated with appropriate serology or further analysis of the pleural fluid. Pleural space infections caused by urease-splitting organisms such as Proteus species may result in a spuriously elevated pleural pH [<a href="#rid68">68</a>]. (See  <a class="medical medical_review" href="/d/html/119910.html" rel="external">"Pleural effusion of extra-vascular origin (PEEVO)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural effusion or masses on imaging – Distinguishing loculated pleural fluid from a pleural mass on chest radiography or CT can be challenging but differences in the CT attenuation can help distinguish fluid from solid masses. However, if organization is advanced, occasionally, a pleural biopsy will be needed to assure that pleural based malignancy is excluded.</p><p></p><p class="bulletIndent1">Chest CT can also help distinguish a lung abscess from empyema. Empyemas are more likely to compress adjacent lung rather than erode it, whereas lung abscesses are more likely to erode adjacent structures. Empyemas typically have thinner, smoother walls than lung abscesses, which tend to have thicker walls and irregular luminal and exterior surfaces. Empyemas tend to form an obtuse angle of interface with the chest wall, compared with lung abscesses, which commonly have an acute angle, although this feature is nonspecific. (See  <a class="medical medical_review" href="/d/html/6688.html" rel="external">"Imaging of pleural effusions in adults", section on 'Computed tomography'</a>.)</p><p></p><p class="headingAnchor" id="H3566050109"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>In most patients, the diagnosis of a parapneumonic effusion and empyema is made by a constellation of clinical signs and symptoms with confirmatory chemical and microbiologic data from pleural fluid  (<a class="graphic graphic_table graphicRef121162" href="/d/graphic/121162.html" rel="external">table 2</a> and <a class="graphic graphic_algorithm graphicRef122289" href="/d/graphic/122289.html" rel="external">algorithm 1</a>). Rarely, a complicated parapneumonic effusion or empyema requires definitive diagnosis on pleural biopsy, most often by thoracoscopy, when microorganisms are demonstrated in or cultured from affected pleural tissue. Occasionally, a retrospective diagnosis may be made when patients present in the late stages of organization (ie, stage 3 (see <a class="local">'Pathogenesis'</a> above)) and fibrous peel is identified during thoracoscopy that requires decortication.</p><p class="headingAnchor" id="H1229805988"><span class="h2">Uncomplicated parapneumonic effusion</span><span class="headingEndMark"> — </span>A parapneumonic effusion is considered uncomplicated or simple when:</p><p class="bulletIndent1"><span class="glyph">●</span>The pleural effusion is free-flowing and too small to sample.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A free-flowing small effusion has a neutrophilic exudate (an elevated protein level &gt;0.5 percent of serum and/or a lactate dehydrogenase (LDH) level &gt;0.6 that in the serum), a normal pH, a normal glucose level, and does not contain microorganisms.</p><p></p><p>In most cases, uncomplicated parapneumonic effusions resolve with appropriate antibiotic therapy and drainage is not generally necessary. However, the threshold to repeat imaging and obtain pleural fluid sampling should be low if patients do not respond adequately to antimicrobial therapy. (See  <a class="medical medical_review" href="/d/html/119384.html" rel="external">"Management and prognosis of parapneumonic pleural effusion and empyema in adults", section on 'Uncomplicated parapneumonic effusion (antibiotics alone)'</a>.)</p><p class="headingAnchor" id="H445200866"><span class="h2">Complicated parapneumonic effusion and empyema</span><span class="headingEndMark"> — </span>A parapneumonic effusion is considered complicated when an exudative effusion has any one or more of the following characteristics: has a pH &lt;7.2 and/or contains evidence of microorganism invasion by culture or Gram stain. In the absence of pH data, a low glucose level &lt;40 mg/dL may be used instead. Although a serum LDH &gt;1000 international units (IU)/L may support the diagnosis, it is non-specific and may simply indicate infection or significant inflammation elsewhere. It is typically large, loculated, or has associated pleural thickening. When it is bacterial, it generally contains a large number of neutrophils. For several reasons, cultures of fluid from complicated parapneumonic effusions are sometimes negative. Although a positive culture is confirmatory, this is not necessary for the diagnosis [<a href="#rid69">69</a>]. An empyema (due to pneumonia) is a complicated parapneumonic effusion in which frank pus is seen on pleural fluid sampling. (See <a class="local">'Thoracentesis and pleural fluid analysis'</a> above.)</p><p>In most cases of complicated parapneumonic effusion, drainage is indicated. Pleural pH &lt;7.2 is the most useful predictor of a complicated clinical course [<a href="#rid70">70</a>]. If pleural pH is not measured, a pleural fluid glucose value &lt;40 mg/dL and/or pleural fluid LDH value &gt;1000 IU/L, or significant loculations are also predictive of the need for tube thoracostomy [<a href="#rid70">70</a>]. Empyema is an absolute indication for chest tube drainage. (See  <a class="medical medical_review" href="/d/html/119384.html" rel="external">"Management and prognosis of parapneumonic pleural effusion and empyema in adults", section on 'Complicated pleural effusion and empyema (antibiotics plus drainage)'</a>.)</p><p>The use of the RAPID score helps risk-stratify patients with pleural infection by five characteristics (renal failure, age, purulence, infectious source, and dietary factors) and may identify those at low, medium, and high risk of mortality from a pleural infection [<a href="#rid71">71</a>]. A calculator is available that estimates 3- and 12-month mortality (<a class="calc calc_professional" href="/d/html/142841.html" rel="external">calculator 1</a>).</p><p class="headingAnchor" id="H3850495546"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112226.html" rel="external">"Society guideline links: Pleural effusion"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and epidemiology</strong> – A parapneumonic effusion is a pleural effusion that forms in the pleural space adjacent to a pneumonia  (<a class="graphic graphic_table graphicRef121161" href="/d/graphic/121161.html" rel="external">table 1</a>). When bacteria or other pathogens infect the pleural space, a complicated parapneumonic effusion or empyema may result. Parapneumonic effusions and empyema are common complications of pneumonia, but an empyema can also develop without the presence of an adjacent pneumonia. The incidence is approximately two to three percent of all pneumonias but appears to be rising. (See <a class="local">'Introduction'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Parapneumonic effusion and empyema may be part of a developmental spectrum that includes three stages  (<a class="graphic graphic_table graphicRef121162" href="/d/graphic/121162.html" rel="external">table 2</a>). Not every patient progresses through each stage.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 1 is typically an early stage where fluid is free-flowing and small, such that resolution occurs with antibiotics alone.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 2 is a fibrinopurulent stage where infection precipitates organization and loculations.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Stage 3 is characterized by a thickened fibrinous coating that may limit lung expansion. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – The microbiology of complicated pleural effusions and empyema vary with source of infection  (<a class="graphic graphic_figure graphicRef121168" href="/d/graphic/121168.html" rel="external">figure 1</a>), route of acquisition, local epidemiology, and patient-specific risk factors  (<a class="graphic graphic_table graphicRef121163" href="/d/graphic/121163.html" rel="external">table 3</a>). (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Parapneumonic</strong> – Parapneumonic pleural space infections typically result as complications of community-acquired pneumonia (CAP) or aspiration pneumonia. Those associated with CAP tend to be caused by the pyogenic bacteria that cause CAP (eg<em>, Streptococcus pneumoniae </em>and <em>Staphylococcus aureus</em>). In contrast, those associated with aspiration pneumonia tend to be polymicrobial and caused by oral streptococci and anaerobes.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Non-parapneumonic</strong> – The list of pathogens associated with non-parapneumonic pleural space infections is more extensive and varies by source  (<a class="graphic graphic_figure graphicRef121168" href="/d/graphic/121168.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suspecting parapneumonic effusion</strong> – Among patients with pneumonia, the presence of risk factors (eg, aspiration, poor dental hygiene, alcohol or intravenous drug abuse, immunosuppression, young or old age, partially treated pneumonia, and gastroesophageal reflux) and the development of a persistent or new fever despite appropriate antibiotics should heighten the suspicion for the development of a parapneumonic effusion or an empyema. The clinical findings of a parapneumonic effusion and empyema are nonspecific and, with the exception of decreased fremitus, overlap with those of pneumonia. (See <a class="local">'Risk factors'</a> above and <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Imaging</strong> – In all patients with pneumonia, the imaging modality that defined the pneumonia should be reexamined for evidence of pleural fluid. Once a pleural effusion is suspected on chest radiography, ultrasonography is typically performed at the bedside to evaluate the nature of the effusion and feasibility of sampling or drainage. CT is generally additionally performed when complications (eg, loculations) are suspected, complex interventions are planned, and/or more detail of the underlying anatomy is expected to help with management. (See <a class="local">'Diagnostic imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thoracentesis</strong> – Most cases of suspected parapneumonic effusion or empyema should be sampled under ultrasound guidance unless the effusion is too small or sampling is deemed unsafe. (See <a class="local">'Thoracentesis and pleural fluid analysis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In some cases, therapeutic thoracentesis is simultaneously performed when symptomatic relief is needed or when drainage is indicated (eg, frank pus is observed).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Fluid should be sent for cell count and differential, chemistries (protein and lactate dehydrogenase [LDH]), Gram stain and culture with additional inoculation of fluid into blood culture bottles (aerobic and anaerobic), pH (drawn directly into an arterial blood gas syringe and analyzed within one hour), and cytology. Special stains and cultures should be requested when unusual organisms or organisms that require special culture conditions are suspected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Several conditions need to be entertained when evaluating a suspected parapneumonic effusion or empyema including other causes of an exudative effusion  (<a class="graphic graphic_table graphicRef54055" href="/d/graphic/54055.html" rel="external">table 4</a>), pleural fluid acidosis (eg, malignancy, tuberculosis, rheumatoid pleurisy, lupus pleuritis, urinothorax, or infused <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>), and pleural masses or lung abscesses. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> <strong>and classification</strong> – In most patients, the diagnosis of a parapneumonic effusion and empyema is made by a constellation of clinical signs and symptoms with confirmatory chemical and microbiologic data from pleural fluid  (<a class="graphic graphic_table graphicRef121162" href="/d/graphic/121162.html" rel="external">table 2</a>). It is rare that pleural biopsy is required. In general, we and others categorize parapneumonic effusions as the following (see <a class="local">'Diagnosis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Uncomplicated</strong> – A parapneumonic effusion is considered <strong>uncomplicated (simple)</strong> when the effusion is free-flowing and too small to sample or when a small free-flowing effusion has a neutrophilic exudate (an elevated protein level &gt;0.5 that in serum and/or a LDH level &gt;0.6 that in serum) with normal pH and glucose levels and does not contain microorganisms. These effusions typically resolve with antibiotics, although the threshold to reimage should be low to look for disease progression.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Complicated</strong> – A parapneumonic effusion is considered <strong>complicated</strong> when an exudative effusion has any one or more of the following characteristics: has a pH &lt;7.2 (or a low glucose level &lt;40 mg/dL in the absence of pH data) and/or contains evidence of microorganism invasion by culture or Gram stain. It is typically large, loculated, and has associated pleural thickening.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Empyema</strong> – An <strong>empyema</strong> is considered present when frank pus is seen on pleural fluid sampling.</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Weese WC, Shindler ER, Smith IM, Rabinovich S. Empyema of the thorax then and now. A study of 122 cases over four decades. Arch Intern Med 1973; 131:516.</a></li><li><a class="nounderline abstract_t">Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J 2008; 15:85.</a></li><li><a class="nounderline abstract_t">Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006; 3:75.</a></li><li><a class="nounderline abstract_t">Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011; 66:663.</a></li><li><a class="nounderline abstract_t">Nayak R, Brogly SB, Lajkosz K, et al. Two Decades of Thoracic Empyema in Ontario, Canada. Chest 2020; 157:1114.</a></li><li><a class="nounderline abstract_t">Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007; 133:346.</a></li><li><a class="nounderline abstract_t">Arnold DT, Hamilton FW, Morris TT, et al. Epidemiology of pleural empyema in English hospitals and the impact of influenza. Eur Respir J 2021; 57.</a></li><li><a class="nounderline abstract_t">Maskell NA, Davies CW, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352:865.</a></li><li><a class="nounderline abstract_t">Alfageme I, Muñoz F, Peña N, Umbría S. Empyema of the thorax in adults. Etiology, microbiologic findings, and management. Chest 1993; 103:839.</a></li><li><a class="nounderline abstract_t">Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160:1682.</a></li><li><a class="nounderline abstract_t">Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 Suppl 4:S248.</a></li><li><a class="nounderline abstract_t">Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110:56.</a></li><li><a class="nounderline abstract_t">Meyer CN, Rosenlund S, Nielsen J, Friis-Møller A. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis 2011; 43:165.</a></li><li><a class="nounderline abstract_t">Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009; 64:592.</a></li><li><a class="nounderline abstract_t">Marks DJ, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS One 2012; 7:e30074.</a></li><li><a class="nounderline abstract_t">Sellares J, López-Giraldo A, Lucena C, et al. Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia. Am J Respir Crit Care Med 2013; 187:1241.</a></li><li><a class="nounderline abstract_t">Neff CC, vanSonnenberg E, Lawson DW, Patton AS. CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage. Radiology 1990; 176:195.</a></li><li><a class="nounderline abstract_t">Hassan M, Cargill T, Harriss E, et al. The microbiology of pleural infection in adults: a systematic review. Eur Respir J 2019; 54.</a></li><li><a class="nounderline abstract_t">Lisboa T, Waterer GW, Lee YC. Pleural infection: changing bacteriology and its implications. Respirology 2011; 16:598.</a></li><li><a class="nounderline abstract_t">Heffner JE. Diagnosis and management of thoracic empyemas. Curr Opin Pulm Med 1996; 2:198.</a></li><li><a class="nounderline abstract_t">Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174:817.</a></li><li><a class="nounderline abstract_t">Luh SP, Chou MC, Wang LS, et al. Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients. Chest 2005; 127:1427.</a></li><li><a class="nounderline abstract_t">Ahmed RA, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006; 119:877.</a></li><li><a class="nounderline abstract_t">Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest 1993; 103:1502.</a></li><li><a class="nounderline abstract_t">Civen R, Jousimies-Somer H, Marina M, et al. A retrospective review of cases of anaerobic empyema and update of bacteriology. Clin Infect Dis 1995; 20 Suppl 2:S224.</a></li><li><a class="nounderline abstract_t">Boyanova L, Vladimir Djambazov, Gergova G, et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe 2004; 10:261.</a></li><li><a class="nounderline abstract_t">Bartlett JG, Gorbach SL, Thadepalli H, Finegold SM. Bacteriology of empyema. Lancet 1974; 1:338.</a></li><li><a class="nounderline abstract_t">Dhiensiri T, Puapairoj S, Susaengrat W. Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand. Radiology 1988; 166:711.</a></li><li><a class="nounderline abstract_t">Chen KY, Hsueh PR, Liaw YS, et al. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000; 117:1685.</a></li><li><a class="nounderline abstract_t">Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962.</a></li><li><a class="nounderline abstract_t">Hulnick DH, Naidich DP, McCauley DI. Pleural tuberculosis evaluated by computed tomography. Radiology 1983; 149:759.</a></li><li><a class="nounderline abstract_t">Park S, Jo KW, Lee SD, et al. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease. Respir Med 2017; 133:36.</a></li><li><a class="nounderline abstract_t">Ko SC, Chen KY, Hsueh PR, et al. Fungal empyema thoracis: an emerging clinical entity. Chest 2000; 117:1672.</a></li><li><a class="nounderline abstract_t">Chen M, Wang X, Yu X, et al. Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. BMC Infect Dis 2015; 15:385.</a></li><li><a class="nounderline abstract_t">Lyche KD, Jensen WA. Pleuropulmonary amebiasis. Semin Respir Infect 1997; 12:106.</a></li><li><a class="nounderline abstract_t">Lal C, Huggins JT, Sahn SA. Parasitic diseases of the pleura. Am J Med Sci 2013; 345:385.</a></li><li><a class="nounderline abstract_t">Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest 2000; 118:1158.</a></li><li><a class="nounderline abstract_t">Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg 2017; 153:e129.</a></li><li><a class="nounderline abstract_t">Scarci M, Abah U, Solli P, et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg 2015; 48:642.</a></li><li><a class="nounderline abstract_t">Davies HE, Davies RJ, Davies CW, BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii41.</a></li><li><a class="nounderline abstract_t">Bedawi EO, Ricciardi S, Hassan M, et al. ERS/ESTS statement on the management of pleural infection in adults. Eur Respir J 2023; 61.</a></li><li><a class="nounderline abstract_t">Heffner JE, Klein JS, Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest 2010; 137:467.</a></li><li><a class="nounderline abstract_t">Svigals PZ, Chopra A, Ravenel JG, et al. The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions. Thorax 2017; 72:94.</a></li><li><a class="nounderline abstract_t">Davis SD, Henschke CI, Yankelevitz DF, et al. MR imaging of pleural effusions. J Comput Assist Tomogr 1990; 14:192.</a></li><li><a class="nounderline abstract_t">Colins JD, Burwell D, Furmanski S, et al. Minimal detectable pleural effusions. A roentgen pathology model. Radiology 1972; 105:51.</a></li><li><a class="nounderline abstract_t">Brixey AG, Luo Y, Skouras V, et al. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011; 16:1000.</a></li><li><a class="nounderline abstract_t">Chen KY, Liaw YS, Wang HC, et al. Sonographic septation: a useful prognostic indicator of acute thoracic empyema. J Ultrasound Med 2000; 19:837.</a></li><li><a class="nounderline abstract_t">Aquino SL, Webb WR, Gushiken BJ. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994; 192:803.</a></li><li><a class="nounderline abstract_t">Waite RJ, Carbonneau RJ, Balikian JP, et al. Parietal pleural changes in empyema: appearances at CT. Radiology 1990; 175:145.</a></li><li><a class="nounderline abstract_t">Kearney SE, Davies CW, Davies RJ, Gleeson FV. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol 2000; 55:542.</a></li><li><a class="nounderline abstract_t">Tsujimoto N, Saraya T, Light RW, et al. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT. PLoS One 2015; 10:e0130141.</a></li><li><a class="nounderline abstract_t">Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest 1989; 95:945.</a></li><li><a class="nounderline abstract_t">España PP, Capelastegui A, Quintana JM, et al. A prediction rule to identify allocation of inpatient care in community-acquired pneumonia. Eur Respir J 2003; 21:695.</a></li><li><a class="nounderline abstract_t">Moffett BK, Panchabhai TS, Anaya E, et al. Computed tomography measurements of parapneumonic effusion indicative of thoracentesis. Eur Respir J 2011; 38:1406.</a></li><li><a class="nounderline abstract_t">Skouras V, Awdankiewicz A, Light RW. What size parapneumonic effusions should be sampled? Thorax 2010; 65:91.</a></li><li><a class="nounderline abstract_t">Everts RJ, Heneghan JP, Adholla PO, Reller LB. Validity of cultures of fluid collected through drainage catheters versus those obtained by direct aspiration. J Clin Microbiol 2001; 39:66.</a></li><li><a class="nounderline abstract_t">Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011; 66:658.</a></li><li><a class="nounderline abstract_t">Ferrer A, Osset J, Alegre J, et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 1999; 18:237.</a></li><li><a class="nounderline abstract_t">Psalididas I. Chest 2018; 154:766.</a></li><li><a class="nounderline abstract_t">Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 2006; 42:1135.</a></li><li><a class="nounderline abstract_t">Maskell NA, Gleeson FV, Darby M, Davies RJ. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions. Chest 2004; 126:2022.</a></li><li><a class="nounderline abstract_t">Porcel JM, Vives M, Cao G, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009; 34:1383.</a></li><li><a class="nounderline abstract_t">Porcel JM, Bielsa S, Esquerda A, et al. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med 2012; 23:447.</a></li><li><a class="nounderline abstract_t">Lee SH, Lee EJ, Min KH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem 2013; 46:1484.</a></li><li><a class="nounderline abstract_t">Chung CL, Hsiao SH, Hsiao G, et al. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions. PLoS One 2013; 8:e53169.</a></li><li><a class="nounderline abstract_t">Khosla R, Khosla SG, Becker KL, Nylen ES. Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions. J Hosp Med 2016; 11:363.</a></li><li><a class="nounderline abstract_t">Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988; 138:184.</a></li><li><a class="nounderline abstract_t">Pine JR, Hollman JL. Elevated pleural fluid pH in Proteus mirabilis empyema. Chest 1983; 84:109.</a></li><li><a class="nounderline abstract_t">Mavroudis C, Ganzel BL, Cox SK, Polk HC Jr. Experimental aerobic-anaerobic thoracic empyema in the guinea pig. Ann Thorac Surg 1987; 43:298.</a></li><li><a class="nounderline abstract_t">Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995; 151:1700.</a></li><li><a class="nounderline abstract_t">White HD, Henry C, Stock EM, et al. Predicting Long-Term Outcomes in Pleural Infections. RAPID Score for Risk Stratification. Ann Am Thorac Soc 2015; 12:1310.</a></li></ol></div><div id="topicVersionRevision">Topic 6702 Version 56.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4699956" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Empyema of the thorax then and now. A study of 122 cases over four decades.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18354748" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Empyema: an increasing concern in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16493154" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Parapneumonic effusions and empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21617169" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Emergence of parapneumonic empyema in the USA.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32386638" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Two Decades of Thoracic Empyema in Ontario, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17258562" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Management of pleural space infections: a population-based analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33334937" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Epidemiology of pleural empyema in English hospitals and the impact of influenza.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15745977" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : U.K. Controlled trial of intrapleural streptokinase for pleural infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8449078" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Empyema of the thorax in adults. Etiology, microbiologic findings, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10556140" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Predictors of outcome and long-term survival in patients with pleural infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8324127" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Anaerobic bacterial infections of the lung and pleural space.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4834618" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Anaerobic infections of the lung and pleural space.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21108539" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Bacteriological aetiology and antimicrobial treatment of pleural empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19131449" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22276145" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23590264" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Influence of previous use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2353091" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : CT follow-up of empyemas: pleural peels resolve after percutaneous catheter drainage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31248959" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The microbiology of pleural infection in adults: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21382129" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pleural infection: changing bacteriology and its implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9363140" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Diagnosis and management of thoracic empyemas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16840746" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The bacteriology of pleural infection by genetic and standard methods and its mortality significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15821225" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Video-assisted thoracoscopic surgery in the treatment of complicated parapneumonic effusions or empyemas: outcome of 234 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17000220" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Thoracic empyema in patients with community-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8486033" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7548560" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A retrospective review of cases of anaerobic empyema and update of bacteriology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16701526" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4131173" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Bacteriology of empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3340766" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pulmonary melioidosis: clinical-radiologic correlation in 183 cases in northeastern Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10858403" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18710327" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6647852" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pleural tuberculosis evaluated by computed tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29173447" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10858401" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Fungal empyema thoracis: an emerging clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26395579" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9195675" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pleuropulmonary amebiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22990049" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Parasitic diseases of the pleura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11035692" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28274565" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The American Association for Thoracic Surgery consensus guidelines for the management of empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26254467" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : EACTS expert consensus statement for surgical management of pleural empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20696693" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36229045" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : ERS/ESTS statement on the management of pleural infection in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20133295" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Diagnostic utility and clinical application of imaging for pleural space infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27613540" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2312846" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : MR imaging of pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5057315" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Minimal detectable pleural effusions. A roentgen pathology model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21651642" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The efficacy of chest radiographs in detecting parapneumonic effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11127008" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Sonographic septation: a useful prognostic indicator of acute thoracic empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8058951" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pleural exudates and transudates: diagnosis with contrast-enhanced CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2315473" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Parietal pleural changes in empyema: appearances at CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10924379" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Computed tomography and ultrasound in parapneumonic effusions and empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26076488" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2707086" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The sun should never set on a parapneumonic effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12762359" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21622586" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Computed tomography measurements of parapneumonic effusion indicative of thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20029043" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : What size parapneumonic effusions should be sampled?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11136750" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Validity of cultures of fluid collected through drainage catheters versus those obtained by direct aspiration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21459855" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Blood culture bottle culture of pleural fluid in pleural infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10385010" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Prospective clinical and microbiological study of pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : </p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16575731" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15596709" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19541708" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Biomarkers of infection for the differential diagnosis of pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22726374" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23570862" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23308155" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26821368" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3059866" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : State of the art. The pleura.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6345098" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Elevated pleural fluid pH in Proteus mirabilis empyema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3548615" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Experimental aerobic-anaerobic thoracic empyema in the guinea pig.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7767510" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26193196" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Predicting Long-Term Outcomes in Pleural Infections. RAPID Score for Risk Stratification.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
